Success Stories: In Just 21 Days, NIW Approval Obtained for an Indian Assistant Scientist in Bioinformatics with Premium Processing Upgrade, and Our Teamwork
Client’s Testimonial:
“My experience with Chen was the best. I would recommend this firm for the excellent service, very professional and caring about my needs and requests.. Excellent communication, they reply you in 24 hours.”
On March 15th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Scientist in the Field of Bioinformatics (Approval Notice).
General Field: Bioinformatics
Position at the Time of Case Filing: Assistant Scientist
Country of Origin: India
State of Residence at the Time of Filing: Florida
Approval Notice Date: March 15th, 2023
Processing Time: 21 days (Premium Processing Requested)
Case Summary:
In the years since our inception, NAILG has grown into a firm with deep roots within the immigrant and nonimmigrant visa processing system. Having worked successfully with over 32,000 clients has given us a deep insight into the workings of the USCIS. And this in turn has helped us assist our clients better. So when we got an NIW (National Interest Waiver) request from an Indian assistant scientist in bioinformatics, we already knew the route we had to take to succeed. After completing the formalities, we worked to collect important data from her documents such as:
- We said that as an expert in the field her proposed endeavor was to work on her research to develop next-generation computer-based approaches and algorithms in order to guide drug discovery and development.
- We found that her research proposal was of great importance because it provided essential tools, techniques, and discoveries for discerning and targeting key complexes in the diagnosis and treatment of major human diseases like cancer and chronic kidney disease, which are pervasive and costly public health crises. As her work provided unprecedented insights into the diagnostic biomarkers and therapeutic susceptibilities of these and numerous other major human diseases, it was clear that her work is of major medical and thus global health importance.
- Additionally, her proposed endeavor also has broad implications for the United States where in 2020, around 1,806,590 new cases of cancer were diagnosed in the United States and 606,520 people were estimated to have died from the disease. With these figures in mind, it was readily apparent that research on the discovery of new diagnostic biomarkers and therapeutic biotargets for cancer is a top priority for the development of next-generation cancer therapeutics. This is of major importance to the U.S. pharmaceutical industry and to the overall national economy.
- We said that her research represents a national boon, as her work has repeatedly provided cutting-edge pipelines, technologies, models, and discoveries for the development of next-generation diagnostics and therapeutics for some of the most devastating human diseases, including but not limited to cancer, chronic kidney disease, and multiple system atrophy.
- Not only this but due to its clear national importance, her research has also been supported with funding from the National Institutes of Health and the Florida Department of Health. And she has completed at least 19 reviews to date. Along with this, her research has resulted in 7 peer-reviewed journal articles (5 of them first-authored or co-first-authored)and these publications have been cited a total of 195 times according to Google Scholar.
- We also asked her to find letters of recommendation from experts who knew her work and understood its significance for the country. Acting on our advice, she was able to obtain 2 letters from other experts supporting her claim to the NIW category.
- And finally, we said that since she has pursued research directly related to her proposed endeavor of developing next-generation computer-based approaches and algorithms for 9 years, she is clearly prepared for any challenges that may come her way in the future.